Paclitaxel chemotherapy in a pregnant patient with bilateral breast cancer

Clinical Breast Cancer

Volumn 5, Issue 4, 2004, Pages 317-319

  Gonzalez Angulo, Ana M ^a   Walters, Ronald S ^a   Carpenter Jr , Robert J ^b   Ross, Merrick I ^a   Perkins, George H ^a   Gwyn, Karin ^a   Theriault, Richard L ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Axillary lymph node; Estrogen receptor; Mastectomy; Progesterone receptor; Taxanes

Indexed keywords

ANTHRACYCLINE; CYCLOPHOSPHAMIDE; DOXORUBICIN; PACLITAXEL; TAMOXIFEN; TAXANE DERIVATIVE;

ADULT; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CASE REPORT; DELIVERY; DRUG DOSE REGIMEN; ECHOMAMMOGRAPHY; FEMALE; FETUS MALFORMATION; GESTATIONAL AGE; HUMAN; INFORMED CONSENT; LYMPH NODE DISSECTION; MALE; MASTECTOMY; NEWBORN; PREGNANCY; PRENATAL CARE; PREOPERATIVE PERIOD; SIDE EFFECT; THORAX WALL;

EID: 9444276662     PISSN: 15268209     EISSN: None     Source Type: Journal    
DOI: 10.3816/CBC.2004.n.037     Document Type: Article

References (15)

1. Gwyn K, Theriault RL. Breast cancer during pregnancy. Oncology 2001; 15:39-46.
2. Capri G, Tarenzi E, Fulfaro F, et al. The role of taxanes in the treatment of breast cancer. Semin Oncol 1996; 23(suppl 2):68-75.
3. Buzdar AU, Singletary SE, Valero V, et al. Evaluation of paclitaxel in adjuvant chemotherapy for patients with operable breast cancer: preliminary data of a prospective randomized trial. Clin Cancer Res 2002; 8:1073-1079.
4. Mamounas EP, Bryant J, Lembersky BC, et al. Paclitaxel (T) following doxorubicin/ cyclophosphamide (AC) as adjuvant chemotherapy for node-positive breast cancer: Results from NSABP B-28. Proc Am Soc Clin Oncol 2003; 22:4a (Abstract #12).
5. De Santis M, Lucchese A, De Carolis S, et al. Metastatic breast cancer in pregnancy: first case of chemotherapy with docetaxel. Eur J Cancer Care 2000; 9:235-237.
6. Sood AK, Shahin MS, Sorosky JI. Paclitaxel chemotherapy for ovarian carcinoma during pregnancy. Gynecol Oncol 2001; 83:599-600.
7. Mendez LE, Mueller A, Salom E, et al. Paclitaxel and carboplatin chemotherapy administered during pregnancy for advanced ovarian cancer. Obstet Gynecol 2003; 102:1200-1202.
8. Moore HCF, Foster RS Jr. Breast cancer and pregnancy. Semin Oncol 2000; 27:646-653.
9. Theriault RL, Gwyn K. Breast cancer and pregnancy. Breast Cancer Manage Treat 2000; 1:1-12.
10. Gwyn K, Theriault RL, Sabin A, et al. Treatment of breast cancer during pregnancy using a standard protocol: update of the MD Anderson experience. Proc Am Soc Clin Oncol 2001; 20:18b (Abstract #1821).
11. Giacalone PL, Lafarge Fand Benos P. Chemotherapy for breast carcinoma during pregnancy. Cancer 1999; 86:2266-2272.
12. Healy C, Dijkstra B, Kelly L, et al. Pregnancy-associated breast cancer. Irish Med J 2002; 95:51-54.
13. Scialli AR, Waterhouse TB, Desesso JM, et al. Protective effect of liposome encapsulation on paclitaxel developmental toxicity in the rat. Teratology 1997; 56:305-310.
14. Kai S, Kohmura H, Hiraiwa E, et al. Reproductive and developmental toxicity studies of paclitaxel. (II)-intravenous administration to rats during the fetal organogenesis. J Toxicol Sci 1994; 19(suppl 1):69-91.
15. Pregnancy categories for prescription drugs. FDA Drug Bull 1982; 12:24-25.